← Eichor
Condition: Primary Antibody Deficiency Disorders Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Primary Antibody Deficiency Disorders

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART Control
Phase 2 · 17 location(s) · ANRS, Emerging Infectious Diseases · NCT05300035Usage of Spirometry in Managing IgG Therapy in CVID With Airway Disease
Phase 4 · 1 location(s) · University of Alabama at Birmingham · NCT05193552Exercise Intervention and Immunodeficiency
NA · 2 location(s) · Yale University · NCT07698197Study of BP-SCIG 20% in Patients With Primary Immunodeficiency (PID)
Phase 3 · 12 location(s) · Biopharma Plasma LLC · NCT07346859Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifest
Phase 2 · 1 location(s) · Paul Szabolcs · NCT07284641Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168Natural History of Bronchiectasis
Phase N/A · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT00943514Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT04339777V-IMMUNE: A Novel Immunoglobulin Therapy for Immunodeficiency
Phase 3 · 1 location(s) · On Pharma Importadora, Exportadora e Distribuidora de Medica · NCT06954441A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs).
Phase 2 · 12 location(s) · Imperial College London · NCT04319367National Registry of Rare Kidney Diseases
Phase N/A · 1 location(s) · UK Kidney Association · NCT06065852Immune Regulation in Patients With Common Variable Immunodeficiency and Related Inborn Errors of Immunity (IEI)
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00001244Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
Phase 2 · 8 location(s) · Memorial Sloan Kettering Cancer Center · NCT06976476Safety and Efficacy of PD-1 ± mFOLFOX6 Neoadjuvant Therapy in Local Advanced sMPCC
Phase 2 · 1 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT06002789Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
Phase 2 · 2 location(s) · National Cancer Institute (NCI) · NCT02579967A Database Survey to Evaluate the Safety of Immune Globulin Subcutaneous (Human), 20% Solution in Participants With Prim
Phase N/A · 1 location(s) · Takeda · NCT06565078Institutional Registry of Rare Diseases
Phase N/A · 1 location(s) · Hospital Italiano de Buenos Aires · NCT06573723
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.